Retraction
Multimodal targeting of tumor vasculature and cancer stem-like cells in sarcomas with VEGF-A inhibition, HIF-1α inhibition, and hypoxia-activated chemotherapy
Paper Information
Record ID:
51697
Author(s):
Journal:
Publication Date:
June 21, 2016
Retraction Date:
February 08, 2024
(1.8 year years ago)
Subjects:
Institutions:
- Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
- Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA
- Threshold Pharmaceuticals, South San Francisco, CA, USA
- Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
Country:
🇺🇸 United StatesArticle Type:
Publisher:
Impact Journals
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.18632/oncotarget.28560Additional Notes:
See also: https://pubpeer.com/publications/A78AF5E5D101678E04CDEC32152FF0
Citations (19)
19
Total Citations0
Post-Retraction19
Pre-Retraction0
Same DayPhosphorylation of IWS1 by AKT maintains liposarcoma tumor heterogeneity through preservation of cancer stem cell phenotypes and mesenchymal-epithelial plasticity
Yu Wang, Hongji Zhang, Alessandro La Ferlita et al. (14 authors)
Oncogenesis
Open Access
Published: May 2023
5 citations
5 citations
258 days before retraction
PIK3R3, a regulatory subunit of PI3K, modulates ovarian cancer stem cells and ovarian cancer development and progression by integrative analysis
Eun Jung Sohn
BMC Cancer
Open Access
Published: Jun 2022
8 citations
8 citations
591 days before retraction
RETRACTED ARTICLE: PIK3R3, part of the regulatory domain of PI3K, is upregulated in sarcoma stem-like cells and promotes invasion, migration, and chemotherapy resistance
Changhwan Yoon, Jun Lü, Sandra Ryeom et al. (5 authors)
Cell Death and Disease
Open Access
Published: Jul 2021
19 citations
19 citations
924 days before retraction
Paper citing Multimodal targeting of tumor vasculature and canc...
Unknown Authors
Unknown Journal
Published: Jul 2021
924 days before retraction
The Hypoxia-Activated Prodrug TH-302: Exploiting Hypoxia in Cancer Therapy
Yue Li, Long Zhao, Xiaofeng Li
Frontiers in Pharmacology
Open Access
Published: Apr 2021
53 citations
53 citations
1025 days before retraction
RETRACTED ARTICLE: PI3K/Akt pathway and Nanog maintain cancer stem cells in sarcomas
Changhwan Yoon, Jun Lü, Brendan C. Yi et al. (7 authors)
Oncogenesis
Open Access
Published: Jan 2021
54 citations
54 citations
1115 days before retraction
Dexamethasone inhibits stemness maintenance and enhances chemosensitivity of hepatocellular carcinoma stem cells by inducing deSUMOylation of HIF‑1α and Oct4
Zhongmin Jiang, Chunyan Zhang, Xiaozhi Liu et al. (10 authors)
International Journal of Oncology
Open Access
Published: Jul 2020
17 citations
17 citations
1310 days before retraction
In silico analysis of hypoxia activated prodrugs in combination with anti angiogenic therapy through nanocell delivery
Cameron Meaney, Sander Rhebergen, Mohammad Kohandel
PLoS Computational Biology
Open Access
Published: May 2020
16 citations
16 citations
1351 days before retraction
Quantitative design strategies for fine control of oxygen in microfluidic systems
Venktesh S. Shirure, Sandra Lam, Bhupinder Shergill et al. (6 authors)
Lab on a Chip
Published: Jan 2020
20 citations
20 citations
1499 days before retraction
Three-Dimensional, Scaffolded Tumor Model to Study Cell-Driven Microenvironment Effects and Therapeutic Responses
Kimberly J. Ornell, Katelyn S. Mistretta, Emily A Newman et al. (5 authors)
ACS Biomaterials Science & Engineering
Published: Nov 2019
14 citations
14 citations
1549 days before retraction
Mathematical Modelling of Cancer Treatments Involving Radiation Therapy and Hypoxia-Activated Prodrugs
Cameron Meaney
Unknown Journal
Published: Aug 2019
1634 days before retraction
Hypoxia, angiogenesis, and metabolism in the hereditary kidney cancers
John C. Chappell, Laura Beth Payne, W. Kimryn Rathmell
Journal of Clinical Investigation
Open Access
Published: Jan 2019
98 citations
98 citations
1859 days before retraction
RETRACTED ARTICLE: Platelet-derived growth factor receptor-α and -β promote cancer stem cell phenotypes in sarcomas
Kevin K. Chang, Changhwan Yoon, Brendan C. Yi et al. (6 authors)
Oncogenesis
Open Access
Published: Jun 2018
36 citations
36 citations
2065 days before retraction
EGLN Inhibition Reduces Gastrointestinal Radiation Toxicity and Improves Survival in a Murine Model of Locally Advanced Pancreatic Cancer
Tara N. Fujimoto, Lauren E. Colbert, Jessica M. Molkentine et al. (9 authors)
bioRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Nov 2017
1 citation
1 citation
2271 days before retraction
Uterine Sarcoma: Modern Treatment Paradigms
Stephanie Ricci, Lisa Rubinsak, Sarah M. Temkin
Current Obstetrics and Gynecology Reports
Published: Oct 2017
2297 days before retraction
Vorinostat suppresses hypoxia signaling by modulating nuclear translocation of hypoxia inducible factor 1 alpha
Chao Zhang, Chunzhang Yang, Michael J. Feldman et al. (14 authors)
Oncotarget
Open Access
Published: May 2017
70 citations
70 citations
2452 days before retraction
An Insertion/Deletion Polymorphism within the Promoter of EGLN2 is Associated with Susceptibility to Colorectal Cancer
Chaoyang Li, Lanjun Feng, Luwei Niu et al. (11 authors)
The International Journal of Biological Markers
Open Access
Published: Feb 2017
15 citations
15 citations
2547 days before retraction
Molecular Pathways: Hypoxia-Activated Prodrugs in Cancer Therapy
Natalia Baran, Marina Konopleva
Clinical Cancer Research
Open Access
Published: Jan 2017
119 citations
119 citations
2564 days before retraction
At the crossroads of cancer stem cells and targeted therapy resistance
Anbang Wang, Le Qu, Linhui Wang
Cancer Letters
Published: Nov 2016
27 citations
27 citations
2654 days before retraction
Quick Stats
Total Citations:
19
Years Since Retraction:
1.8 year
Open Access:
Yes
Last Checked:
Jul 24, 2025